Journal Article Epublish
PubMed: 40659409 DOI: 10.1136/bmjopen-2024-097338
Correlation between fatigue and pulmonary involvement in the post-COVID-19 condition: a cross-sectional study 6-12 months after hospital discharge.
BMJ Open 15(7):e097338
Authors: Mateus Satoru Kajiwara, Celina Almeida Lamas, Luis Augusto Visani de Luna, Thais Suemi Yokoyama, Pedro Rizzi de Oliveira, Rodrigo Caruso Chate, Marcio Valente Yamada Sawamura, Marta Imamura, Carlos Roberto Ribeiro de Carvalho, João Marcos Salge
Affiliations
- Instituto do Coração, Divisão de Pneumologia, Universidade de São Paulo Hospital das Clínicas, São Paulo, São Paulo, Brazil.
- Instituto de Radiologia, Universidade de São Paulo Hospital das Clínicas, São Paulo, São Paulo, Brazil.
- Department of Legal Medicine, Bioethics, Occupational Medicine and Physical Medicine and Rehabilitation, Universidade de São Paulo, São Paulo, SP, Brazil.
- Instituto do Coração, Divisão de Pneumologia, Universidade de São Paulo Hospital das Clínicas, São Paulo, São Paulo, Brazil.
Abstract
INTRODUCTION
Post-COVID-19 conditions (PCC) may include pulmonary sequelae, fatigue and other symptoms, but its mechanisms are not fully elucidated.
OBJECTIVE
This study investigated the correlation between fatigue and the presence of pulmonary abnormalities in PCC patients with respiratory involvement 6-12 months after hospitalisation.
DESIGN
Cross-sectional study.
SETTING
A tertiary hospital in Brazil.
PARTICIPANTS
315 patients, aged ≥18 years, were considered eligible based on SARS-CoV-2 infection confirmed by reverse transcription-PCR.
METHODS
Pulmonary function tests (PFT), cardiopulmonary exercise tests (CPET), chest CT and hand grip were performed. The following scales were applied: Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) scale, Euroqol 5 Dimensions quality of life (EQ-5D) and Hospital Anxiety and Depression Scale (HADS). Participants were divided between the fatigue group (FACIT-F≤30) and the non-fatigue group (FACIT-F>30). For the statistical analysis, the primary outcome was the difference in the diffusing capacity of the lungs for carbon monoxide (DLCO) between groups. Considered secondary outcomes were differences in PFT, CPET, chest CT, hand grip, EQ-5D and HADS.
RESULTS
The fatigue group had 81 patients (25.7%) against 234 (74.3%). PFT and CPET showed no significant difference in DLCO and oxygen consumption peak values between groups. The fatigue group had a lower workload (mean 55.3±21.3 watts vs 66.5±23.2 watts, p=0.003), higher breathing reserve (median 41.9% (33.8-52.5) vs 37.7% (28.9-47.1), p=0.028) and lower prevalence of ground glass opacity (60.8% vs 77.7%, p=0.003) and reticulation (36.7% vs 54.9%, p=0.005) in chest CT. The fatigue group had higher anxiety (57% vs 24%, p<0.001), depression (50.6% vs 13.6%, p<0.001), lower health-related quality of life (median 50 (32-63) vs 80 (61.3-88.3), p<0.001) and lower hand grip strength (median 15.8 (6-21) kgf vs 21 (12.1-30) kgf, p<0.001).
CONCLUSION
Fatigue in patients with PCC 6-12 months after hospitalisation is relatively common and had weak correlation with pulmonary disorders. Our results suggested fatigue could be strongly related with peripheral disorders such as reduced musculoskeletal strength or psychosocial limitations.
MeSH
Quality Of Life, Cross-Sectional Studies, Covid-19, Fatigue, Hand Strength